Financial Results : Jamjoom Pharma 9M 2024 profit up 23% to 304.9M; Q3 at SAR 95M

Jamjoom Pharma 9M 2024 profit up 23% to 304.9M; Q3 at SAR 95M

27/10/2024 Argaam Exclusive

View other reports

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) posted a net profit of SAR 304.9 million in 9M 2024, leaping 23% from SAR 247.9 million a year earlier.



Financials (M)

Item 9m 2023 9m 2024 Change‬
Revenues 891.86 1,058.77 18.7 %
Gross Income 584.93 661.99 13.2 %
Operating Income 271.14 326.52 20.4 %
Net Income 247.92 304.92 23.0 %
Average Shares 70.00 70.00 -
EPS (Riyals) 3.54 4.36 23.0 %

The profit increase was buoyed by 18.7% revenue growth year-on-year (YoY) due to higher sales volume in main markets, price adjustment for some products, new product launches, cost management efficiency, and the return on investment in Algeria.



Current Quarter Comparison (M)

Compared With The
Item Q3 2023 Q3 2024 Change‬
Revenues 292.61 327.58 11.9 %
Gross Income 187.23 194.41 3.8 %
Operating Income 84.67 95.67 13.0 %
Net Income 77.25 94.99 23.0 %
Average Shares 70.00 70.00 -
EPS (Riyals) 1.10 1.36 23.0 %

The third-quarter earnings jumped 23% to SAR 95 million, compared to SAR 77.25 million in the year-ago period.

 

On a quarterly basis, the company posted an 11.2% decline in Q3 profit from SAR 106.95 million.

 

Shareholders’ equity, no minority interest, increased to SAR 1.44 billion as of Sept. 30, 2024, compared to SAR 1.36 billion a year earlier.

 

Attached Documents

 

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.